Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors
Related Posts
Chou P, Lee K, Grant-Kels JM, Farshchian M. Ethical Considerations of Omitting Genital Examination During Skin Cancer Screening. J Am Acad Dermatol. 2026 Apr 28:S0190-9622(26)02571-5.[...]
Zhou AE, Moon J, Al-Dojaily Y, Kim J, Feng H. Practice Patterns and Geographic Distribution of Fellowship-Trained MD-PhD Mohs Surgeons in the United States. Dermatol[...]
Cortes JA, Nong Y, Smart K, Aflatooni S, Palma G, Johnsen N, Ure A, Armstrong AW. Chronic Urticaria Is Independently Associated with Atherosclerotic Cardiovascular Disease:[...]